China Resources Double-Crane Pharmaceutical Co.,Ltd.

Symbol: 600062.SS

SHH

23.35

CNY

Trhová cena dnes

  • 17.5971

    Pomer P/E

  • -0.5329

    Pomer PEG

  • 24.20B

    MRK Cap

  • 0.01%

    Výnos DIV

China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062-SS) Finančné výkazy

Na grafe môžete vidieť predvolené čísla v dynamike pre China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS). Príjmy spoločnosti zobrazuje priemerná hodnota NaN M, ktorá je NaN % gowth. Priemerný hrubý zisk za celé obdobie je NaN M, čo je NaN %. Priemerný pomer hrubého zisku je NaN %. Rast čistého zisku za minuloročné výsledky spoločnosti je NaN %, ktorý sa rovná NaN % % v priemere za celú históriu spoločnosti.,

Súvaha

Keď sa ponoríme do fiškálnej trajektórie spoločnosti China Resources Double-Crane Pharmaceutical Co.,Ltd., pozorujeme priemerný rast aktív. Je zaujímavé, že táto miera predstavuje , čo odráža maximá aj minimá spoločnosti. V porovnaní medzi štvrťrokmi sa tento údaj upraví na . Pohľad späť za minulý rok odhaľuje celkovú zmenu aktív o NaN. Hodnota akcionárov, vyjadrená celkovým vlastným imaním akcionárov, sa oceňuje na NaN v mene vykazovania. Medziročná zmena tohto aspektu je NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

balance-sheet.row.cash-and-short-term-investments

034572830.73637.6
3262.2
2602.1
1975.7
1248.1
1486.9
778.2
1366.3
1410
1004.7
1104.5
1056.6
1023.5
1028.4
654.3
452
668.7
573.7
444.7
513.7
555.3
302.8
318.7
140.7
337.9
9.2
14.3
1.1

balance-sheet.row.short-term-investments

0240.7200.5803.6
851.9
758.1
878.7
-18
-33.2
-42.6
-31.4
0
0
0
0
0
0
0
0
0.1
0
0
0
0
98.4
0
0
0
0
0
0

balance-sheet.row.net-receivables

02403.52362.82127
2216.7
2130.9
2017.5
1892.7
1864.7
1737.4
1386.6
1886.8
1969.7
1849.3
1408.8
1239.8
1012.2
1358.8
971.1
1095.3
1209.3
1378.7
1197.8
720.6
44.7
37.8
39.6
86.3
23.4
67.9
76.3

balance-sheet.row.inventory

01562.41878.61665.5
1289.3
1146
973.6
974.2
762.8
808.7
653.7
566.1
779.1
701
709.9
600.1
604.5
528.6
466.5
507.3
485.2
563.6
584.7
407.4
174.5
141.5
117.3
30.2
36.5
0
1.8

balance-sheet.row.other-current-assets

0215.592.892.5
32
159.7
168.4
665.1
191.4
435
514.4
18.2
138
42.2
18.2
6.2
37.3
-231
-69.9
-137.1
-129.7
-72.7
-115
0.5
294.9
210.2
79.3
-26.2
-8.3
-3.2
-2.9

balance-sheet.row.total-current-assets

07638.571657522.6
6800.3
6038.7
5135.2
4780.2
4305.8
3759.3
3921.1
3881.2
3891.6
3697
3193.5
2869.6
2682.5
2310.6
1819.6
2134.1
2138.5
2314.2
2181.2
1683.8
816.9
708.3
376.9
428.2
60.8
79
76.3

balance-sheet.row.property-plant-equipment-net

03852.53506.62957.1
2673
2621.8
2632.5
2449.6
2361.4
2444.2
2053.6
2017.5
2027.8
1827.4
1563.2
1432.5
1223.9
997.8
1274.6
1504.9
1552.1
1538.7
1120.4
912.9
452.4
336.9
236
123.7
93.5
53.3
55

balance-sheet.row.goodwill

0906.1935788.2
796.4
839.8
864.4
797
391.7
391.7
109.5
109.5
110.3
66.6
9.1
9.1
9.1
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

02482.322811899.5
1650.7
1637.4
1525.6
1315.8
1031.9
978
385.4
384.7
343
307.9
233.1
201.7
147.8
163.6
52.2
53.3
74.9
78.5
75.9
45.2
60.3
61.6
67.5
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

03388.332162687.7
2447.1
2477.2
2390
2112.8
1423.6
1369.7
494.9
494.2
453.3
374.5
242.2
210.7
156.9
164.4
52.2
53.3
74.9
78.5
75.9
45.2
60.3
61.6
67.5
0
0
0
0

balance-sheet.row.long-term-investments

0403.1149.8-500.2
-481.9
-723.9
-855.9
20.1
49.7
64.3
53
0
0
0
0
0
0
0
0
109.6
0
0
0
98.7
40.7
0
0
0
0
0
0

balance-sheet.row.tax-assets

0192124.773.8
52.2
50.3
53.5
50.2
42.8
29.2
27.7
29.9
21.7
23.6
27.2
27
24.6
14.3
0
0
0
0
0
5.7
111.5
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

022.1320.6935.1
925.7
812.7
951
24.9
58.3
96.5
68.9
58.1
113.5
154.4
179.4
177.1
181.2
186.3
112.9
11.4
259.7
326.4
239
0
2.4
78
60.6
22.8
0
0
0

balance-sheet.row.total-non-current-assets

078587317.66153.5
5616.2
5238.2
5171
4657.7
3935.8
4003.8
2698.2
2599.7
2616.2
2380
2012.1
1847.4
1586.6
1362.8
1439.7
1679.2
1886.7
1943.6
1435.3
1062.5
667.3
476.6
364.1
146.5
93.5
53.3
55

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

015496.514482.513676.1
12416.5
11276.9
10306.2
9437.9
8241.5
7763.1
6619.3
6480.9
6507.8
6077
5205.5
4717
4269
3673.5
3259.3
3813.3
4025.3
4257.9
3616.5
2746.3
1484.2
1184.8
741
574.7
154.3
132.3
131.3

balance-sheet.row.account-payables

0696.7744.5847.4
848
690.8
547.3
469.2
395.7
400.7
488.4
428.5
959.9
718.3
568.3
518.1
440.5
593
624.2
745.1
924.6
1041.8
829.2
499.7
192.8
116.4
33.1
19.6
8.2
11.5
18

balance-sheet.row.short-term-debt

0432.932.129.5
6.6
64.9
75
0
0
30
0
210
295
400.7
279.4
278
341.5
311
318.5
717.8
885.4
875.8
697.9
374.5
249.3
186.6
106
75
31.5
0.4
0

balance-sheet.row.tax-payables

065.7201.7138.9
122.6
131.3
153.6
113.9
108.7
121.4
68.2
112.3
62.9
150.7
68.7
55.7
60.9
120.3
65.2
101.4
113.6
94.6
131.3
84.9
69.9
41.2
21.3
2.4
-0.2
0
0

balance-sheet.row.long-term-debt-total

029.9232.935.4
151
0.5
7
1.5
1.5
11.2
1.2
0
0
0
13.4
0
0
16
23
4.1
4.1
204
8.6
52
1
2.3
10
0
4
0
0

Deferred Revenue Non Current

0180.6198.8153.8
100.9
97.8
113.8
108.2
111.4
132.7
108.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01822.32042.357.2
43.9
43.9
1352.2
739.9
619.6
120.4
337.9
89.6
65.9
59.6
52
43.8
29.3
68.8
31.4
55.8
38.1
43.6
49
32.1
18.2
35.7
0.7
0
2.6
3.5
18.4

balance-sheet.row.total-non-current-liabilities

0364741.1468.6
369.5
258.9
269.6
380.2
187.8
224.9
108.6
115.8
118.7
81.8
89.5
54.1
41.3
52.2
29.9
52.4
65.5
264.7
45.9
106.3
6.7
7.2
11
0
4
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

029.932.935.4
121.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

03526.13752.93199.5
3039.5
2600.3
2397.6
1589.3
1203.1
1329.2
934.9
1144.7
1801
1733.7
1279.6
1182.2
1118.6
1308.8
1264.1
1874
2297.9
2541.2
2011.6
1256.3
628.9
473.6
199.6
101.8
48.5
29.2
36.4

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

01039.71043.21043.2
1043.2
1043.2
1043.2
869.4
724.5
724.5
571.7
571.7
571.7
571.7
571.7
571.7
476.4
441.1
441.1
441.1
441.1
441.1
441.1
339.3
305.7
235.2
147
147
88
86.8
86.8

balance-sheet.row.retained-earnings

09670.68560.98196.4
7580.1
6892.1
6186.8
5517.4
4939.2
4374.9
3643.3
3296.9
2610.9
2216
1867.4
1511.8
1249.4
980.8
527
462.5
326.3
289
244.3
171.4
132.8
71.9
86.5
38
4.5
1.9
1.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

0380594.3561.9
566.8
563.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

00-175.7103.9
103.9
103.9
609.9
1070
1022.5
1007.2
1464.1
1464.1
1471
1470
1424.1
1387.1
1353.7
775.6
847.5
824.3
771
761.7
718.8
772
352.1
385.2
300.5
287.9
13.3
14.4
6.2

balance-sheet.row.total-stockholders-equity

011090.410022.69905.5
9294.1
8602.5
7839.9
7456.8
6686.2
6106.7
5679.1
5332.7
4653.6
4257.7
3863.2
3470.5
3079.5
2197.5
1815.5
1727.9
1538.4
1491.8
1404.2
1282.8
790.6
692.2
534
472.9
105.8
103.1
94.9

balance-sheet.row.total-liabilities-and-stockholders-equity

015496.514482.513676.1
12416.5
11276.9
10306.2
9437.9
8241.5
7763.1
6619.3
6480.9
6507.8
6077
5205.5
4717
4269
3673.5
3259.3
3813.3
4025.3
4257.9
3616.5
2746.3
1484.2
1184.8
741
574.7
154.3
132.3
131.3

balance-sheet.row.minority-interest

0699.4707571.1
82.9
74.1
68.7
391.8
352.3
327.2
5.2
3.5
53.1
85.6
62.8
64.3
70.9
167.2
179.7
211.4
188.9
224.8
200.7
207.2
64.7
19
7.5
0
0
0
0

balance-sheet.row.total-equity

011789.810729.610476.6
9377
8676.6
7908.6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0643.8350.3303.4
370.1
34.3
22.8
2.1
16.5
21.7
21.6
26.7
26.7
64.1
85.3
83.4
81.5
82.9
103.4
109.7
252.2
325.6
194.5
98.7
139.1
70.1
53.2
0
0
0
0

balance-sheet.row.total-debt

0462.926564.9
6.6
64.9
82
0
0
41.2
1.2
210
295
400.7
292.8
278
341.5
311
318.5
721.9
889.5
1079.7
706.4
426.5
250.3
188.9
116
75
35.5
0.4
0

balance-sheet.row.net-debt

0-2753.4-2365.3-2769.1
-2403.6
-1779.1
-1015.1
-1248.1
-1486.9
-737
-1365.1
-1200
-709.7
-703.8
-763.8
-745.5
-686.9
-343.3
-133.5
53.3
315.9
635
192.7
-128.8
45.9
-129.9
-24.7
-262.9
26.3
-13.9
-1.1

Výkaz peňažných tokov

Finančné prostredie spoločnosti China Resources Double-Crane Pharmaceutical Co.,Ltd. zaznamenalo za posledné obdobie pozoruhodnú zmenu voľného peňažného toku, ktorý vykazuje posun NaN. Spoločnosť nedávno rozšírila svoje základné imanie vydaním NaN, čo v porovnaní s predchádzajúcim rokom znamená rozdiel NaN. Výsledkom investičnej činnosti spoločnosti bolo čisté použitie hotovosti vo výške NaN v mene vykazovania. V porovnaní s predchádzajúcim rokom ide o posun o NaN. V tom istom období spoločnosť zaznamenala NaN, NaN a NaN, ktoré sú významné pre pochopenie investičných a splátkových stratégií spoločnosti. Finančné aktivity spoločnosti viedli k čistému použitiu hotovosti vo výške NaN, pričom medziročný rozdiel predstavoval NaN. Okrem toho spoločnosť vyčlenila NaN na výplatu dividend svojim akcionárom. Zároveň uskutočnila ďalšie finančné manévre, označované ako NaN, ktoré tiež výrazne ovplyvnili jej peňažný tok v tomto období. Tieto zložky spolu vytvárajú komplexný obraz o finančnej situácii spoločnosti a strategickom prístupe k riadeniu peňažných tokov.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

013331215.4972.1
1013.5
1066.5
989.5
882.1
739.2
664.8
543.7
873.4
630.5
552.5
533
463.5
396.5
457.6
179.2
190
-25.4
51.6
146.2
162
138.6
75.3
61.1

cash-flows.row.depreciation-and-amortization

0655.5540.6465
371.7
357.4
343.7
335.8
313.7
269.3
235.6
267.7
214.8
176.4
157.9
135.5
126.4
105.7
99.7
118.3
123.6
101.4
89.6
79.2
43.1
62.6
12.7

cash-flows.row.deferred-income-tax

0-18.1-20.7-23.8
-3.1
-3.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-1705.53623.8
3.1
3.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-412.6-413.5-143.5
-62.4
-31.3
152.6
-35.3
-276.3
-213.7
-65.7
-368.2
-459.9
-244.8
-202.8
-214.2
-244.3
-197
-119.4
-227.4
103.3
-196.3
-145
-166.8
-26.1
-27.4
-93.2

cash-flows.row.account-receivables

0-488.7-266.2-130.7
-216.2
-369.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0315.7-34.3-384.5
-146.8
-185.1
-4.9
-202.9
31.6
33.5
-85.2
-46.2
-78.1
18.8
-111.8
11.4
-104.9
-64.1
-14.1
-55
75.8
64.8
-58.4
-74.5
-33
-27.9
-87.1

cash-flows.row.account-payables

0-221.6-92.2395.5
303.6
526.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-18-20.7-23.8
-3.1
-3.2
157.5
167.5
-307.9
-247.2
19.5
-321.9
-381.8
-263.6
-91.1
-225.6
-139.4
-133
-105.3
-172.4
27.5
-261.1
-86.6
-92.3
7
0.6
-6.1

cash-flows.row.other-non-cash-items

01798.5-16.147.2
37.3
47.3
-16.8
4.5
-5.4
-19.1
4.7
-226.7
10.5
27.4
21.6
-42.7
53.2
-130.8
144.2
59
252.2
192.3
49.9
66.6
17.2
21.1
5.6

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-604.5-525.5-491.7
-348.1
-241.6
-228.7
-154.8
-110
-168.5
-142.4
-217.7
-221.9
-338.8
-370.2
-285.2
-309.2
-136.2
-171.7
-127.1
-196.8
-376
-252
-175.6
-86.8
-69.9
-130.3

cash-flows.row.acquisitions-net

0-127.2-409.236.6
42.7
-112.8
-257.7
-648.2
1.2
-697.1
149.4
194
-111.3
-50.3
0
0
0
171.8
41.6
12.8
0
43.5
2.2
4.8
0.2
0
0

cash-flows.row.purchases-of-investments

0-2340-1350-3199.9
-2421.4
-3064.1
-2019.7
-1290.8
-735
-2607.5
-1280
-2.9
-4.6
-76.5
0
6.8
0
-24.1
-10.8
-15.7
0
-152.7
-55.7
-59.4
-169.3
-30
-26.8

cash-flows.row.sales-maturities-of-investments

023032951.73051.7
2296
2342.7
1678.7
864.9
1003
2723.7
898.6
119
94.9
55.8
0
2.8
1.2
2
45.4
261.6
11.7
4.5
2.1
103.7
5.7
1
0

cash-flows.row.other-investing-activites

060.9-0.233.4
12.9
6.5
4
96.4
4.2
39.2
22
6.4
34.6
5.7
62.4
43.9
138.1
13
7.7
-21.9
32.7
7.8
-1.3
53.2
-2
0
12.9

cash-flows.row.net-cash-used-for-investing-activites

0-707.8666.8-569.8
-418
-1069.3
-823.5
-1132.5
163.3
-710.1
-352.3
98.9
-208.3
-404.2
-307.8
-231.6
-170
26.6
-87.9
109.7
-152.4
-472.9
-304.7
-73.3
-252.2
-98.8
-144.2

cash-flows.row.debt-repayment

0-9.3-6.2-47.7
-64.3
-306.9
-36.6
0
-40
-182.9
-210
-265
-694.8
-595.3
-283.8
-470.8
-350.3
-314.5
-689.3
-895.3
-983.1
-1113.8
-635.7
-576.7
-358.5
-224.9
-173.6

cash-flows.row.common-stock-issued

0-29.7144.70
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-1-290.90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-300.5-801.8-302.6
-319.3
-299.2
-91.1
-193.7
-184.7
-3.4
-199.7
-217.2
-250.8
-155
-145.7
-79.9
-111.3
-93.2
-106.4
-43.9
-48.1
-89.1
-68
-56.2
-41.6
0
-8.9

cash-flows.row.other-financing-activites

0-17.8-337-28.3
-2.5
81.2
-675.4
-99.7
0
-397.7
0
371.5
613.4
694.5
275.5
386.4
723.7
304.6
392.3
775.9
858.8
1457.9
826.1
915.9
365.2
370.2
143.2

cash-flows.row.net-cash-used-provided-by-financing-activities

0-358.3-1291.2-378.6
-386.2
-524.9
-803.1
-293.5
-224.7
-583.9
-409.7
-110.7
-332.3
-55.8
-154
-164.3
262.2
-103.1
-403.4
-163.3
-172.4
255
122.4
283.1
-34.9
145.3
-39.3

cash-flows.row.effect-of-forex-changes-on-cash

03.712.31.3
-0.1
0
0
-0.1
0
0.1
0
-0.4
-0.1
0.8
0
0
0
0.1
0.4
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0585.8729.6393.8
555.9
-154.4
-157.5
-238.9
709.9
-592.5
-43.7
534
-144.5
52.3
47.9
-53.9
423.9
159.1
-187.1
86.1
129
-69
-41.6
350.8
-114.3
178.1
-197.2

cash-flows.row.cash-at-end-of-period

03216.32614.71885.1
1491.3
935.4
1089.8
1247.3
1486.2
776.3
1366.3
1410
876
1020.6
968.2
920.3
974.2
550.3
375
562.1
573.7
444.7
513.7
555.3
204.5
318.7
140.7

cash-flows.row.cash-at-beginning-of-period

02630.41885.11491.3
935.4
1089.8
1247.3
1486.2
776.3
1368.8
1410
876
1020.6
968.3
920.3
974.2
550.3
391.2
562.1
476
444.7
513.7
555.3
204.5
318.7
140.7
337.9

cash-flows.row.operating-cash-flow

01650.81341.71340.9
1360.2
1439.8
1469
1187.1
771.2
701.3
718.4
546.2
396
511.5
509.7
342
331.7
235.5
303.7
139.8
453.7
148.9
140.6
141
172.8
131.5
-13.8

cash-flows.row.capital-expenditure

0-604.5-525.5-491.7
-348.1
-241.6
-228.7
-154.8
-110
-168.5
-142.4
-217.7
-221.9
-338.8
-370.2
-285.2
-309.2
-136.2
-171.7
-127.1
-196.8
-376
-252
-175.6
-86.8
-69.9
-130.3

cash-flows.row.free-cash-flow

01046.3816.1849.2
1012.1
1198.1
1240.3
1032.3
661.2
532.9
576
328.6
174.2
172.7
139.5
56.9
22.5
99.3
132.1
12.6
256.9
-227
-111.4
-34.6
86
61.7
-144.1

Riadok výkazu ziskov a strát

Príjmy China Resources Double-Crane Pharmaceutical Co.,Ltd. zaznamenali v porovnaní s predchádzajúcim obdobím zmenu o NaN%. Hrubý zisk spoločnosti 600062.SS sa vykazuje vo výške NaN. Prevádzkové náklady spoločnosti sú NaN, ktoré vykazujú zmenu o NaN% oproti minulému roku. Náklady na odpisy sú NaN, čo predstavuje NaN% zmenu oproti poslednému účtovnému obdobiu. Prevádzkové náklady sa vykazujú vo výške NaN, ktorá vykazuje NaN% medziročnú zmenu. Výdavky na predaj a marketing predstavujú NaN, čo je NaN% zmena oproti predchádzajúcemu roku. EBITDA na základe posledných čísel je NaN, čo predstavuje NaN% medziročný nárast. Prevádzkový zisk je NaN, ktorý vykazuje NaN% zmenu v porovnaní s predchádzajúcim rokom. Zmena čistého príjmu je NaN%. Čistý príjem za posledný rok bol NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

income-statement-row.row.total-revenue

010089.39446.99111.5
8503.9
9381
8225.1
6421.8
5494.8
5138.4
4281
6834.6
6989.3
6383.4
5366.8
5037.9
4951.5
4556.6
4049.1
4597.4
4195.7
4249.2
3686.3
2382.7
1168.3
723.2
350.7
236.3
208.4
168.1
156.7

income-statement-row.row.cost-of-revenue

04948.24231.84030
3145.2
3430.6
3014.4
2733.7
2576.5
2473.1
2206
4470
4661.5
4321.5
3424.9
3327.6
3417.7
3186.3
2902.8
3365.2
3085.9
3096.8
2544.8
1500.4
634
447.5
227.2
160.9
131.1
103.4
107

income-statement-row.row.gross-profit

05141.25215.15081.5
5358.7
5950.3
5210.7
3688.1
2918.3
2665.3
2075
2364.6
2327.9
2061.9
1941.9
1710.4
1533.8
1370.4
1146.3
1232.3
1109.8
1152.4
1141.5
882.2
534.4
275.6
123.4
75.4
77.3
64.7
49.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-14.5639.7612.8
682.9
589.3
-5.2
-6.4
69.3
49.5
27.5
33.3
33
62.5
31.4
22.9
18.6
180.9
48.6
-16.2
12.1
20.3
21.1
19.8
11.3
16.5
12.6
4.4
0
0
0.6

income-statement-row.row.operating-expenses

03684.53901.53978.5
4121.8
4645.2
4031.3
2612.3
2060.8
1918.6
1453.1
1561.8
1613.5
1412.5
1335.3
1163.9
1071.9
913.5
920.4
1017.2
996.7
972.3
932.6
684.3
355.9
173.9
54.6
27.6
23.7
16.7
14.1

income-statement-row.row.cost-and-expenses

08632.68133.48008.5
7267
8075.8
7045.7
5346.1
4637.3
4391.8
3659
6031.7
6275
5734
4760.2
4491.5
4489.6
4099.7
3823.1
4382.3
4082.6
4069.1
3477.4
2184.7
989.9
621.4
281.8
188.5
154.8
120.1
14.1

income-statement-row.row.interest-income

052.988.554.4
48.5
20.3
12
10.9
9.7
26.8
24.4
16.8
12.8
12.2
5.8
5.1
0
0
7.7
15
4.8
5.3
9
3.8
3
0
0
0
0
0
0

income-statement-row.row.interest-expense

015.410.611.6
3.7
9.5
8.2
0
2.4
6.5
4.7
22.5
24.2
23.5
12.5
14.5
12.8
11.4
27
49.4
46.8
48.4
37.3
28.2
18.1
12
-3.5
-0.8
3
3.8
3.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

097.38.5-15.8
-14.2
-0.7
4.8
-21.8
49.3
60.1
36.5
263.9
48.4
53.6
10.3
15
8.8
117.8
9.5
12.4
-99.2
-104.7
-27
-20
-6
-2.2
14.5
5.1
-3
-3.8
-3.9

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-14.5639.7612.8
682.9
589.3
-5.2
-6.4
69.3
49.5
27.5
33.3
33
62.5
31.4
22.9
18.6
180.9
48.6
-16.2
12.1
20.3
21.1
19.8
11.3
16.5
12.6
4.4
0
0
0.6

income-statement-row.row.total-operating-expenses

097.38.5-15.8
-14.2
-0.7
4.8
-21.8
49.3
60.1
36.5
263.9
48.4
53.6
10.3
15
8.8
117.8
9.5
12.4
-99.2
-104.7
-27
-20
-6
-2.2
14.5
5.1
-3
-3.8
-3.9

income-statement-row.row.interest-expense

015.410.611.6
3.7
9.5
8.2
0
2.4
6.5
4.7
22.5
24.2
23.5
12.5
14.5
12.8
11.4
27
49.4
46.8
48.4
37.3
28.2
18.1
12
-3.5
-0.8
3
3.8
3.9

income-statement-row.row.depreciation-and-amortization

0655.5582.3491
444.5
427.3
343.7
335.8
313.7
269.3
235.6
267.7
214.8
176.4
157.9
135.5
126.4
105.7
99.7
118.3
123.6
101.4
89.6
79.2
43.1
62.6
12.7
-1
3
3.8
-45.8

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

01456.71406.11136.9
1229.3
1262.5
1189.3
1060.4
843.2
764.3
638.4
1033.9
731.3
655.2
592.7
542.2
452
393.8
222.1
270
29.9
116.7
208.2
189
175.1
93.2
73.5
48.9
50.7
44.2
31.7

income-statement-row.row.income-before-tax

015541414.61121.2
1215
1261.8
1184.1
1053.9
906.8
806.8
658.4
1066.8
762.8
703
616.9
561.4
470.7
574.7
253.1
240.7
28
106.2
205.6
193.4
179.4
104.6
84.7
53.1
50.7
44.2
31.7

income-statement-row.row.income-tax-expense

0240.6199.3149.1
201.5
195.3
194.7
171.8
167.5
141.9
114.7
193.3
132.2
150.5
83.9
98
74.2
117.1
67.5
51.9
53.4
54.7
59.4
31.3
40.8
29.4
23.6
5.5
-3
0.2
0.2

income-statement-row.row.net-income

013331180.1935.7
1005.2
1055.1
968.6
842.6
714.2
661.1
541.9
870.7
614.4
529
520.1
451.5
380.6
437.6
164.9
186.6
4.7
64.6
168.4
157.7
128.9
75.9
60.9
47.5
50.7
44
31.5

Často kladené otázky

Čo je China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) celkové aktíva?

China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) celkové aktíva sú 15496483691.000.

Aký je ročný obrat podniku?

Ročné príjmy sú N/A.

Aké je ziskové rozpätie podniku?

Zisková marža firmy je 0.554.

Aký je voľný peňažný tok podniku?

Voľný peňažný tok je 1.160.

Aká je čistá zisková marža podniku?

Čistá zisková marža je 0.134.

Aké sú celkové výnosy podniku?

Celkové príjmy sú 0.147.

Aká je China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) čistý zisk (čistý príjem)?

Čistý zisk (čistý príjem) je 1333029471.000.

Aký je celkový dlh firmy?

Celkový dlh je 462877986.000.

Aké je číslo prevádzkových nákladov?

Prevádzkové výdavky sú 3684461873.000.

Aký je údaj o hotovosti spoločnosti?

Peňažné prostriedky podniku sú 0.000.